41 – 50 of 112
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Healthcare professionals' perceptions of working on lifestyle management for patients with early rheumatoid arthritis - a qualitative study
Drake Af Hagelsrum, Klara LU ; Mogard, Elisabeth LU
; Bremander, Ann
LU
; Lindqvist, Elisabet
LU
and Larsson, Ingrid
LU
(2023)
In International Journal of Qualitative Studies on Health and Well-being
18(1).
p.2241225-2241225
- Contribution to journal › Article
-
Mark
Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis
- Contribution to journal › Article
-
Mark
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice : Results from the ARTIS programme
Frisell, Thomas ; Bower, Hannah ; Morin, Matilda ; Baecklund, Eva ; Di Giuseppe, Daniela ; Delcoigne, Benedicte ; Feltelius, Nils ; Forsblad-D'Elia, Helena ; Lindqvist, Elisabet LU
and Lindström, Ulf
, et al.
(2023)
In Annals of the Rheumatic Diseases
82(5).
p.601-610
- Contribution to journal › Article
-
Mark
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: Data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries
- Contribution to journal › Article
-
Mark
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis : A Decision Tree Analysis by Indication
- Contribution to journal › Article
-
Mark
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis : an observational nationwide study
- Contribution to journal › Article
-
Mark
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)
Frodlund, Martina ; Nived, Per LU ; Chatzidionysiou, Aikaterini ; Södergren, Anna ; Klingberg, Eva ; Bengtsson, Anders LU ; Hansson, Monika ; Olsson, Sophie LU
; Pin, Elisa
and Klareskog, Lars
, et al.
(2023)
In Vaccine
41(20).
p.3247-3257
- Contribution to journal › Article
-
Mark
Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout
- Contribution to journal › Article
-
Mark
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis : results from five Nordic biologics registries
- Contribution to journal › Article
-
Mark
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
- Contribution to journal › Article